Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge is advising Vimian Group AB (publ) (“Vimian”) and the principal shareholder Fidelio Capital AB (“Fidelio”) in connection with a private placement and subsequent listing on Nasdaq First North Growth Market with first day of trading on 18 June 2021
Mandate

Vinge is advising Vimian Group AB (publ) (“Vimian”) and the principal shareholder Fidelio Capital AB (“Fidelio”) in connection with a private placement and subsequent listing on Nasdaq First North Growth Market with first day of trading on 18 June 2021

June 18, 2021 Banking and Finance M&A

Vinge is advising Vimian and the principal shareholder Fidelio in connection with a private placement and subsequent listing on Nasdaq First North Growth Market with first day of trading on 18 June 2021, and also with the reorganization preceding the listing. The price in the private placement values Vimian to c. SEK 29.6 billion.

The Vinge team primarily consists of Jonas Bergström, Dain Hård Nevonen, Linnéa Sellström, Johanna Wiberg, Hanna Risberg, Anders Sundin Lundberg, Matthias Pannier, Stina Bengtsson, Manne Bergström, Annika Nyberg Ekenberg, Benjamin Vafaeian, Amanda Steen and Annie Fällström. Albert Wållgren, Linn Adelwald, Josefine Lanker, Seyran Sahin,  Felix Möller, Caroline Krassén and  Lave White advises on financing matters and VDR assistant Nathalie Hughes .

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025